Advertisement
Advertisement
Trending on OncLive
1
Revumenib + Intensive Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Harboring Genetic Alterations in KMT2A, NPM1, or NUP98: Updated Phase 1 Results From SNDX-5613-0708
2
Epcoritamab Plus Lenalidomide Improves PFS vs R-GemOx in R/R DLBCL
3
Tremelimumab + durvalumab + chemotherapy vs pembrolizumab + chemotherapy in 1L non-squamous metastatic NSCLC with STK11, KEAP1 and/or KRAS mutations: Interim analysis of the phase 2b TRITON study
4
Dr Orloff on Key Findings From the Phase 2/3 OptimUM-02 Trial in Uveal Melanoma
5